380 related articles for article (PubMed ID: 10192364)
1. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Dwarakanath BS; Adhikari JS; Jain V
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
Varshney R; Dwarakanath B; Jain V
Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
[TBL] [Abstract][Full Text] [Related]
4. Optimization of tumor radiotherapy. Part VI: Modification of tumor glucose metabolism for increasing the bioavailability of 2-deoxy-D-glucose (2-DG) in a murine tumor model.
Sharma RK; Singh S; Degaonkar M; Raghunathan P; Maitra A; Jain V
Strahlenther Onkol; 2000 Mar; 176(3):135-43. PubMed ID: 10742835
[TBL] [Abstract][Full Text] [Related]
5. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
Kalia VK; Devi NK
Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
[TBL] [Abstract][Full Text] [Related]
6. 2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines.
Dwarakanath BS; Khaitan D; Ravindranath T
Cancer Biol Ther; 2004 Sep; 3(9):864-70. PubMed ID: 15254410
[TBL] [Abstract][Full Text] [Related]
7. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line.
Khaitan D; Chandna S; Arya MB; Dwarakanath BS
Cancer Biol Ther; 2006 Sep; 5(9):1142-51. PubMed ID: 16855378
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamide.
Varshney R; Gupta S; Dwarakanath BS
Technol Cancer Res Treat; 2004 Dec; 3(6):659-63. PubMed ID: 15560724
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
Kalia VK; Prabhakara S; Narayanan V
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
Kalia VK
Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829
[TBL] [Abstract][Full Text] [Related]
11. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose.
Kalia VK
Indian J Med Res; 1999 May; 109():182-7. PubMed ID: 10643143
[TBL] [Abstract][Full Text] [Related]
12. Optimization of tumour radiotherapy: Part V--Radiosensitization by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumour.
Dwarakanath BS; Singh S; Jain V
Indian J Exp Biol; 1999 Sep; 37(9):865-70. PubMed ID: 10687280
[TBL] [Abstract][Full Text] [Related]
13. The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
Gupta S; Mathur R; Dwarakanath BS
Cancer Biol Ther; 2005 Jan; 4(1):87-94. PubMed ID: 15711125
[TBL] [Abstract][Full Text] [Related]
14. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
Swamy RK; Manickam J; Adhikari JS; Dwarakanath BS
Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake, localization and photodynamic effects of haematoporphyrin derivative in human glioma and squamous carcinoma cell lines.
Gupta S; Dwarakanath BS; Muralidhar K; Jain V
J Photochem Photobiol B; 2003 Feb; 69(2):107-20. PubMed ID: 12633983
[TBL] [Abstract][Full Text] [Related]
16. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of radionuclide induced cytotoxicity by 2-deoxy-D-glucose in human tumor cell lines.
Shrivastava V; Mishra AK; Dwarakanath BS; Ravindranath T
J Cancer Res Ther; 2006; 2(2):57-64. PubMed ID: 17998676
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma.
Kawata M; Ogi K; Nishiyama K; Miyamoto S; Nakagaki T; Shimanishi M; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2017 Nov; 46(10):979-985. PubMed ID: 28640935
[TBL] [Abstract][Full Text] [Related]
19. In vivo NMR spectroscopic studies on the bioenergetic changes induced by metabolic modulators in Ehrlich ascites tumour cells.
Sharma RK; Hanssum H; Jain V
Indian J Biochem Biophys; 1996 Apr; 33(2):122-30. PubMed ID: 8754623
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice.
Farooque A; Singh N; Adhikari JS; Afrin F; Dwarakanath BS
PLoS One; 2014; 9(9):e108131. PubMed ID: 25248151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
